Biotech · Private company

Monteris Medical

Track this companyFree. Adds Monteris Medical to your Dealase workspace and tells you when its record changes.

Clinical trials91 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline10

REMASTer: REcurrent Brain Metastases After SRS TrialNA · RECRUITING · started May 10, 2022ClinicalTrials.gov NCT05124912 · fetched Nov 12, 2026
PatiEnt Neuropsychological outcomeS After laseR AblationCOMPLETED · started Sep 29, 2021ClinicalTrials.gov NCT05075850 · fetched Nov 12, 2026
LITT and Pembrolizumab in Recurrent Brain MetastasisPHASE1 · TERMINATED · started Jan 10, 2020ClinicalTrials.gov NCT04187872 · fetched Nov 12, 2026
Feasibility Study on LITT for Newly Diagnosed GlioblastomaPHASE1 · TERMINATED · started Aug 15, 2017ClinicalTrials.gov NCT02880410 · fetched Nov 12, 2026
Feasibility Study on LITT for Medical Refractory EpilepsyNA · TERMINATED · started Apr 21, 2017ClinicalTrials.gov NCT02820740 · fetched Nov 12, 2026
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate SystemCOMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02392078 · fetched Nov 12, 2026
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective RegistryCOMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02389855 · fetched Nov 12, 2026
Laser Ablation After Stereotactic RadiosurgeryCOMPLETED · started Jul 1, 2012ClinicalTrials.gov NCT01651078 · fetched Nov 12, 2026
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain TumorsPHASE1 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00747253 · fetched Nov 12, 2026